FDA calls for inclusion of Omicron BA.4/5 in future boosters
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaProduct LifecycleRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaProduct Lifecycle